418 related articles for article (PubMed ID: 25882296)
1. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane.
Yoshida-Moriguchi T; Campbell KP
Glycobiology; 2015 Jul; 25(7):702-13. PubMed ID: 25882296
[TBL] [Abstract][Full Text] [Related]
2. The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition.
Praissman JL; Willer T; Sheikh MO; Toi A; Chitayat D; Lin YY; Lee H; Stalnaker SH; Wang S; Prabhakar PK; Nelson SF; Stemple DL; Moore SA; Moremen KW; Campbell KP; Wells L
Elife; 2016 Apr; 5():. PubMed ID: 27130732
[TBL] [Abstract][Full Text] [Related]
3. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
[TBL] [Abstract][Full Text] [Related]
4. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy.
Goddeeris MM; Wu B; Venzke D; Yoshida-Moriguchi T; Saito F; Matsumura K; Moore SA; Campbell KP
Nature; 2013 Nov; 503(7474):136-40. PubMed ID: 24132234
[TBL] [Abstract][Full Text] [Related]
5. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
Elife; 2023 Feb; 12():. PubMed ID: 36723429
[TBL] [Abstract][Full Text] [Related]
6. HNK-1 sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan.
Sheikh MO; Venzke D; Anderson ME; Yoshida-Moriguchi T; Glushka JN; Nairn AV; Galizzi M; Moremen KW; Campbell KP; Wells L
Glycobiology; 2020 Sep; 30(10):817-829. PubMed ID: 32149355
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
[TBL] [Abstract][Full Text] [Related]
8. 3D structural analysis of protein O-mannosyl kinase, POMK, a causative gene product of dystroglycanopathy.
Nagae M; Mishra SK; Neyazaki M; Oi R; Ikeda A; Matsugaki N; Akashi S; Manya H; Mizuno M; Yagi H; Kato K; Senda T; Endo T; Nogi T; Yamaguchi Y
Genes Cells; 2017 Apr; 22(4):348-359. PubMed ID: 28251761
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
Manya H; Endo T
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
[TBL] [Abstract][Full Text] [Related]
10. Glycobiology of α-dystroglycan and muscular dystrophy.
Endo T
J Biochem; 2015 Jan; 157(1):1-12. PubMed ID: 25381372
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycosylation of dystroglycan due to T192M mutation: a molecular insight behind the fact.
Bhattacharya S; Das A; Ghosh S; Dasgupta R; Bagchi A
Gene; 2014 Mar; 537(1):108-14. PubMed ID: 24361964
[TBL] [Abstract][Full Text] [Related]
12. Glycomarkers for muscular dystrophy.
Hewitt JE
Biochem Soc Trans; 2011 Jan; 39(1):336-9. PubMed ID: 21265799
[TBL] [Abstract][Full Text] [Related]
13. POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan.
Walimbe AS; Okuma H; Joseph S; Yang T; Yonekawa T; Hord JM; Venzke D; Anderson ME; Torelli S; Manzur A; Devereaux M; Cuellar M; Prouty S; Ocampo Landa S; Yu L; Xiao J; Dixon JE; Muntoni F; Campbell KP
Elife; 2020 Sep; 9():. PubMed ID: 32975514
[TBL] [Abstract][Full Text] [Related]
14. Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan.
Han R; Kanagawa M; Yoshida-Moriguchi T; Rader EP; Ng RA; Michele DE; Muirhead DE; Kunz S; Moore SA; Iannaccone ST; Miyake K; McNeil PL; Mayer U; Oldstone MB; Faulkner JA; Campbell KP
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12573-9. PubMed ID: 19633189
[TBL] [Abstract][Full Text] [Related]
15. Defective glycosylation in muscular dystrophy.
Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
[TBL] [Abstract][Full Text] [Related]
16. Laminin G-like domains: dystroglycan-specific lectins.
Hohenester E
Curr Opin Struct Biol; 2019 Jun; 56():56-63. PubMed ID: 30530204
[TBL] [Abstract][Full Text] [Related]
17. Glycomic analyses of mouse models of congenital muscular dystrophy.
Stalnaker SH; Aoki K; Lim JM; Porterfield M; Liu M; Satz JS; Buskirk S; Xiong Y; Zhang P; Campbell KP; Hu H; Live D; Tiemeyer M; Wells L
J Biol Chem; 2011 Jun; 286(24):21180-90. PubMed ID: 21460210
[TBL] [Abstract][Full Text] [Related]
18. Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands.
Rojek JM; Spiropoulou CF; Campbell KP; Kunz S
J Virol; 2007 Jun; 81(11):5685-95. PubMed ID: 17360738
[TBL] [Abstract][Full Text] [Related]
19. HNK-1 sulfotransferase-dependent sulfation regulating laminin-binding glycans occurs in the post-phosphoryl moiety on α-dystroglycan.
Nakagawa N; Takematsu H; Oka S
Glycobiology; 2013 Sep; 23(9):1066-74. PubMed ID: 23723439
[TBL] [Abstract][Full Text] [Related]
20. Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy.
Brockington M; Torelli S; Prandini P; Boito C; Dolatshad NF; Longman C; Brown SC; Muntoni F
Hum Mol Genet; 2005 Mar; 14(5):657-65. PubMed ID: 15661757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
